Jinxin Fertility Group Limited disclosed a fresh on-market repurchase to the Hong Kong Stock Exchange, reinforcing its capital-management programme.

Latest transaction • Shares bought back: 2.69 million ordinary shares on 3 June 2026. • Price range: HKD 2.28–2.33; volume-weighted average HKD 2.3113. • Cash outlay: HKD 6.22 million. • Treatment: the entire tranche is designated for cancellation.

Outstanding share structure • Issued share capital remains at 2.71 billion shares, with no treasury stock held. • Shares repurchased but not yet cancelled now total 50.68 million, equal to roughly 1.87 % of the existing share base.

Mandate progress • Shareholders authorised the current buyback mandate on 26 June 2025 for up to 274.47 million shares. • Aggregate repurchases under this mandate have reached 90.34 million shares, consuming 32.92 % of the approved capacity and representing 3.29 % of the share count on the mandate date. • In accordance with HKEX rules, the company is restricted from issuing new shares or selling treasury shares until 3 July 2026.

Compliance The company confirmed that all repurchases were executed on-market in line with Hong Kong Listing Rules and the terms set out in its explanatory statement dated 4 June 2025.